The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

C• B••••••••• L••

Pharmaceuticals, B••••••••• & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $43,621
sum of BDC pieces, a lower bound
Fair value
$43.8M
101c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Mar 21, 2030
no dated debt inside 24 months
On the tape since
Sep 30, 2025
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $43,621101cSOFR+635 bpMar 21, 20301
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
F••••••• P•••••• L•••••• F•••term loan first lien
Investment F•••• L••• - T••• L••• R•••••••• R••• and S••••• S•••+635 I••••••• R••• 10.0% M
$43,621$43.8M
101c
SOFR+635 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$43,621$43.8M101c0
Mar 31, 20261$44.3M$44.0M100c0
Dec 31, 20251$45.0M$44.5M100c0
Sep 30, 20251$45.7M$45.2M100c0
What changed
Every change including routine ones
Identity
Group key
C• B•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Pharmaceuticals, B••••••••• & Life Sciencesreportedas one filer wrote it